Kate Coleman, FNP-BC
Family · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kate Coleman’s office at (888) 731-8994 to ask if they take your plan before you enroll.
Medicaid work
$344,898 in 2024
Medicaid paid $344,898 for 12,495 billed services this clinician did in 2024, up to 172 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,586 | $343,766 |
| Short return visit (20+ min) | 1,285 | $1,017 |
| Screening performed and negative | 24 | $116 |
| Pain severity quantified; pain present (COA) (ONC) | 698 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 1,438 | $0 |
| Medication list documented in medical record (COA) | 364 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 364 | $0 |
| BODY MASS INDEX DOCD | 894 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 24 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,462 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 239 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 142 | $0 |
| 2024 | 12,495 | 24 | 172 | $344,898 |
| 2023 | 10,280 | 18 | 173 | $379,920 |
| 2022 | 1,576 | 10 | 113 | $59,726 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,836 | $373,872 |
| Short return visit (20+ min) | 1,264 | $3,437 |
| Return visit (30+ min) | 1,262 | $2,083 |
| Short return visit | 119 | $321 |
| Screening performed and negative | 32 | $203 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 81 | $4 |
| Pain severity quantified; pain present (COA) (ONC) | 93 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 423 | $0 |
| Medication list documented in medical record (COA) | 343 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 343 | $0 |
| BODY MASS INDEX DOCD | 618 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,602 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 320 | $57,088 |
| Short return visit (20+ min) | 201 | $1,994 |
| Return visit (30+ min) | 224 | $644 |
| BODY MASS INDEX DOCD | 116 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 305 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 24 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 305 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 54 | $0 |
| Long return visit (40+ min) | 15 | $0 |
Drugs they prescribed that Part D paid
$26,378
Pharmacies billed $26,378 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
316 generic and fewer than 11 brand-name prescriptions · $26,378 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 14 | $13,269 | $948 |
| Albuterol Sulfate Hfa | 32 | $939 | $29 |
| Losartan-Hydrochlorothiazide | 11 | $189 | $17 |
| Atorvastatin | 23 | $155 | $7 |
| Losartan | 14 | $139 | $10 |
See all 7 drugs
| Ozempic | 14 | $13,269 | $948 |
| Albuterol Sulfate Hfa | 32 | $939 | $29 |
| Losartan-Hydrochlorothiazide | 11 | $189 | $17 |
| Atorvastatin | 23 | $155 | $7 |
| Losartan | 14 | $139 | $10 |
| Lisinopril | 12 | $114 | $10 |
| Amlodipine Besylate | 11 | $37 | $3 |
Year by year
| 2024 | 369 | 71 | None | None | $26,378 |
| 2023 | 174 | 48 | 0% (0) | None | $17,986 |
| 2022 | 39 | 19 | 0% (0) | None | $614 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Albuterol Sulfate Hfa | 13 | $534 | $41 |
| Atorvastatin | 15 | $333 | $22 |
| Fluticasone Propionate | 11 | $229 | $21 |
| Lisinopril | 11 | $163 | $15 |
Money from drug and device companies
$121 in 2025
| 2025 | 5 | 5 | None | $121 |
| 2024 | 3 | 4 | None | $97 |
| 2023 | 2 | 2 | None | $122 |
| 2022 | 4 | 4 | None | $79 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ViiV Healthcare | Apretude | $31 | 1 payment
|
| Novo Nordisk | Wegovy | $30 | 1 payment
|
| Boston Scientific | General - Pain Management | $27 | 1 payment
|
| Astellas Pharma US | Veozah | $19 | 1 payment
|
| CooperSurgical | Paragard T 380a | $14 | 1 payment
|
See all 5 published payments
| Novo Nordisk | Meals · 2025-07-09 | Wegovy | $30 |
| CooperSurgical | Meals · 2025-05-16 | Paragard T 380a | $14 |
| ViiV Healthcare | Meals · 2025-05-01 | Apretude | $31 |
| Astellas Pharma US | Meals · 2025-04-03 | Veozah | $19 |
| Boston Scientific | Meals · 2025-01-27 | General - Pain Management | $27 |
See earlier years (2024, 2023, 2022)
2024: $97
| Lilly USA | Jardiance | $53 | 2 payments
|
| Hologic Sales and Service | Aptima | $28 | 1 payment
|
| Tempus AI | None | $16 | 1 payment
|
2023: $122
| Organon | Nexplanon | $107 | 1 payment
|
| Novo Nordisk | Wegovy | $15 | 1 payment
|
2022: $79
| Dexcom | Dexcom G6 Transmitter | $23 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Pfs | $22 | 1 payment
|
| Nevro | Omnia | $19 | 1 payment
|
| Novo Nordisk | Wegovy | $15 | 1 payment
|
Professional record
- NPI
- 1578299343
- Licence
- CA 95017963
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2022-07-25
- NPI last updated
- 2025-10-01
- NPI record certified
- 2025-10-01
This is when the NPI record was last certified, not a medical board exam.